Public, NASDAQ:SCMP
NASDAQ Global Market
Sucampo files marketing authorization application for Amitiza in Switzerland
Date: Wed, 11 Jun 2008 00:42:12 GMT
Tags:
Sucampo files marketing authorization application for Amitiza in Switzerland
Pharmaceutical Business Review - Jun 11, 2008
Pharmaceutical Business Review - Jun 11, 2008
The marketing authorization application ( MAA ) was filed with Swissmedic by Sucampo Pharmaceuticals's branch office in Basel , Switzerland.The submission is part of the ongoing development of ...
Sucampo and Takeda Introduce Amitiza 8mcg Capsules in US
Date: Wed, 28 May 2008 20:49:55 GMT
Tags:
Sucampo and Takeda Introduce Amitiza 8mcg Capsules in US
RedOrbit - May 28, 2008
RedOrbit - May 28, 2008
Sucampo Pharmaceuticals and Takeda Pharmaceuticals North America have announced that Amitiza 8mcg capsules are now available by prescription in pharmacies across the US for the treatment of irritable ...
Sucampo and Takeda introduce Amitiza 8mcg capsules in US
Date: Wed, 28 May 2008 17:49:14 GMT
Tags:
Sucampo and Takeda introduce Amitiza 8mcg capsules in US
Trading Markets (press release) - May 28, 2008
Trading Markets (press release) - May 28, 2008
May 28 , 2008 ( Datamonitor via COMTEX ) - - SCMP | Quote | Chart | News | PowerRating - - Sucampo Pharmaceuticals and Takeda Pharmaceuticals North America have announced that Amitiza 8mcg capsules ...
AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome With Constipation in Adult Women
Date: Tue, 27 May 2008 16:30:33 GMT
Tags:
AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome With Constipation in Adult Women
CNNMoney.com - May 27, 2008
AMITIZA 8 mcg Dose Is the Only Widely Available FDA-Approved Prescription Medication for Irritable Bowel Syndrome With Constipation - Market Wire (press release)
CNNMoney.com - May 27, 2008
Sucampo Pharmaceuticals , Inc . ( NASDAQ : SCMP ) and Takeda Pharmaceuticals North America , Inc . today announced that AMITIZA ~® ( lubiprostone ) 8 mcg capsules are now available by prescription ...
Sucampo, Takeda's Amitiza now available to treat IBS with constipation in women - ForbesAMITIZA 8 mcg Dose Is the Only Widely Available FDA-Approved Prescription Medication for Irritable Bowel Syndrome With Constipation - Market Wire (press release)
Sucampo Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript
Date: Mon, 26 May 2008 19:23:14 GMT
Tags:
Sucampo Pharmaceuticals Inc. Q1 2008 Earnings Call Transcript
Reuters - May 26, 2008
Reuters - May 26, 2008
Thomson Reuters is the world's largest international multimedia news agency , providing investing news , world news , business news , technology news , headline news , small business news , news ...
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Date: Tue, 15 Jul 2008 15:45:40 Etc/GMT
Tags:
Diamond Management & Technology Consultants, Sucampo Pharmaceuticals and Momenta Pharmaceuticals lead small-cap percentage gainers (SmallCapInvestor.com)
Date: Fri, 11 Jul 2008 15:51:32 Etc/GMT
Tags:
SUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Date: Wed, 11 Jun 2008 19:46:25 Etc/GMT
Tags:
Sucampo Pharma Europe Submits Marketing Authorization Application in Switzerland (Business Wire)
Date: Mon, 9 Jun 2008 12:30:00 Etc/GMT
Tags:
BETHESDA, Md.----Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Pharma Europe, Ltd. , filed a Marketing Authorization Application in Switzerland for AMITIZA for the indication of Chronic Idiopathic Constipation in adults.
AMITIZA(R) (lubiprostone) 8 mcg Now Available to Treat Irritable Bowel Syndrome with Constipation in Adult Women (PR Newswire)
Date: Tue, 27 May 2008 15:38:00 Etc/GMT
Tags:
Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc. today announced that AMITIZA® 8 mcg capsules are now available by prescription in pharmacies across the U.S. for the treatment of Irritable Bowel Syndrome with Constipation in women 18 years and older.